Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico
Dengvaxia is the first dengue vaccine recommended in the United States (U.S.). It is recommended for children aged 9–16 y with laboratory-confirmed previous dengue infection and living in areas where dengue is endemic. We conducted focus groups with parents and in-depth interviews with key informant...
Збережено в:
| Автори: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2024-12-01
|
| Серія: | Human Vaccines & Immunotherapeutics |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2323264 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|